Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

United Health Products Inc (OP: UEEC )

1.050 USD +0.010 (+0.96%)
Streaming Delayed Price Updated: 11:02 AM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about United Health Products Inc

< Previous 1 2 3 Next >
United Health Products Bolsters Management Team and Issues Chairman’s Letter to Shareholders
United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), developer, manufacturer and marketer of HemoStyp®, a patented Neutralized Oxidized Regenerated Cellulose (NORC) hemostatic agent,... 
From Business Wire News Releases
United Health Products Announces Leadership Changes
United Health Products, Inc. (OTC: UEEC), (“UHP” or the "company”), developer, manufacturer and marketer of HemoStyp®, a patented Neutralized Oxidized Regenerated Cellulose (NORC) hemostatic agent,... 
From Business Wire News Releases
United Health Products Announces Journal of Wound Care to Publish HemoStyp® Human Trial Peer Reviewed Article
United Health Products, Inc. (OTC: UEEC) (“UHP” or the “Company”), developer, manufacturer and marketer of HemoStyp, a patented Oxidized Regenerated Cellulose (ORC), today announced that the Journal of... 
From Business Wire News Releases
United Health Products Submits HemoStyp® Completed PMA Response to FDA
United Health Products, Inc. (OTCPK: UEEC, “UHP”) today announced that it has submitted documents requested by the FDA in conjunction with its PMA (Class III) application to use HemoStyp in internal... 
From Business Wire News Releases
United Health Products Announces HemoStyp® Human Trial Results to be Available on ClinicalTrials.gov
United Health Products, Inc. (OTCPK: UEEC, “UHP”) today announced that it has uploaded the full results of its Human Trial study, Efficacy and Safety of HemoStyp as an Adjunct for Management of... 
From Business Wire News Releases
United Health Products Files HemoStyp® Hydrocolloid Patents
United Health Products, Inc. (OTC: UEEC) (“UHP” or the “Company”), today announced that it has filed a non-provisional patent application with the U.S. Patent & Trademark Office for the hydrocolloid... 
From Business Wire News Releases
United Health Products Announces FDA Update Post-Dialysis Patch Product Developed
United Health Products, Inc. (OTC: UEEC), (“UHP” or the “company”), manufacturer and marketer of HemoStyp®, an Oxidized Regenerated Cellulose that is patented through Oct 2029 (US Patent 8,557,874 Oct... 
From Business Wire News Releases
United Health Products Issues Progress Report
United Health Products, Inc. (OTC: UEEC) (UHP or the company) today announced that it is proceeding with its Premarket Approval (PMA) application for Class III approval to the FDA for HemoStyp®. In... 
From Business Wire News Releases
HemoStyp® Human Trial Results Article Submitted to American Journal of Surgery
United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), developer, manufacturer and marketer of HemoStyp, an Oxidized Regenerated Cellulose, today announced that four surgeons who... 
From Business Wire News Releases
United Health Products Issues Progress Report
United Health Products (UHP) (OTCPK: UEEC) today announced that 2019 was a pivotal year for the company in which it: 
From Business Wire News Releases
United Health Products Completes Safety and Efficacy Animal Study for HemoStyp® Hydrocolloid Product
United Health Products (UHP) (OTC: UEEC) today announced that it had completed a safety and efficacy animal study for its HemoStyp hydrocolloid product, for which it filed a patent application in... 
From Business Wire News Releases
United Health Products Reschedules Corporate Update Call
From GlobeNewswire News Releases
United Health Products to Host Corporate Update Call
From GlobeNewswire News Releases
HemoStyp® Human Trial Results Journal Article to be Submitted for Peer Review
From GlobeNewswire News Releases
United Health Products Announces Positive Results from HemoStyp® Human Clinical Trial
From GlobeNewswire News Releases
United Health Products to Move Manufacturing to U.S.
From GlobeNewswire News Releases
United Health Products Files Defamation Lawsuit Against Short Sellers
From GlobeNewswire News Releases
United Health Products Announces Submission of Premarket Approval (PMA) Application to the U.S. FDA for the HemoStyp® Device for Use in Surgical Procedures
From GlobeNewswire News Releases
United Health Products Appoints Dr. Gerard Abate Chief Medical Director
Dr. Ramey to Present Paper on HemoStyp® at IVECCS 
From GlobeNewswire News Releases
Recent Publicity About United Health Products
From GlobeNewswire News Releases
Corrected News Release - United Health Products Announces Completion of Human Trial Study
From GlobeNewswire News Releases
United Health Products Announces Completion of Human Trial Study
From GlobeNewswire News Releases
Technological Advancements Aid Medical Practitioners in Combatting Cancer
FinancialBuzz.com News Commentary 
From PR Newswire
United Health Products Announces Completion of Pathology and Study of Preclinical Bone Application of HemoStyp®
From GlobeNewswire News Releases
United Health Products Files New Patent Application Method of Forming and Using a Hemostatic Hydrocolloid
From GlobeNewswire News Releases
United Health Products Announces the Completion of Human Trial Surgery Enrollment
From GlobeNewswire News Releases
United Health Products Issues Shareholder Update
United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, today announced... 
From GlobeNewswire News Releases
United Health Products Announces Completion of IQVIA Independent Market Assessment for HemoStyp® in Support of Review of Strategic Alternatives
United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that... 
From GlobeNewswire News Releases
United Health Products Retains IQVIA to Conduct U.S. Market Commercialization Study of HemoStyp® in Support of Société Générale’s Strategic Review
United Health Products, Inc. (OTC: UEEC), (“UHP” or “the company”), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that... 
From GlobeNewswire News Releases
United Health Products Announces 2018 Results
United Health Products, Inc. (OTC: UEEC) (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, today filed its Form... 
From GlobeNewswire News Releases
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]